Burosumab

IRB
CHLA-18-00340
X-linked Hypophosphatemia Disease Monitoring Program – (XLH-DMP)

To collect information on the long-term effects of XLH on children and adults who have participated in burosumab clinical trials, adults and children who have not participated in burosumab clinical trials, and who may or may not have been treated with burosumab during the course of the study.

Study Details
Clinical Trials Government Identifier
NCT03651505
Keywords
burosumab chromosomal, hypophosphatemia, XLH
Study Type
Drug Treatment
Eligibility
Child, Adult, Older Adult X-linked Hypophosphatemia
Does this study also recruit healthy volunteers?
No
Enrollment Status
Closed
Coordinator Contact
Rebeca Martinez
Contact Email
rebmartinez@chla.usc.edu